BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

896 related articles for article (PubMed ID: 33574119)

  • 1. Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories.
    Harritshøj LH; Gybel-Brask M; Afzal S; Kamstrup PR; Jørgensen CS; Thomsen MK; Hilsted L; Friis-Hansen L; Szecsi PB; Pedersen L; Nielsen L; Hansen CB; Garred P; Korsholm TL; Mikkelsen S; Nielsen KO; Møller BK; Hansen AT; Iversen KK; Nielsen PB; Hasselbalch RB; Fogh K; Norsk JB; Kristensen JH; Schønning K; Kirkby NS; Nielsen ACY; Landsy LH; Loftager M; Holm DK; Nilsson AC; Sækmose SG; Grum-Schwensen B; Aagaard B; Jensen TG; Nielsen DM; Ullum H; Dessau RB
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33574119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.
    Chapuy-Regaud S; Miédougé M; Abravanel F; Da Silva I; Porcheron M; Fillaux J; Diméglio C; Izopet J
    Microbiol Spectr; 2021 Dec; 9(3):e0137621. PubMed ID: 34937195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays.
    Harley K; Gunsolus IL
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33106364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
    Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
    Front Public Health; 2020; 8():620222. PubMed ID: 33681115
    [No Abstract]   [Full Text] [Related]  

  • 5. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
    Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
    Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of six antibody assays and two combination assays for COVID-19.
    Yamamoto M; Okazaki K; Kitai Y; Shinohara K; Yukawa S; Noguchi T; Tanaka M; Matsumura Y; Nishiyama Y; Nagao M
    Virol J; 2022 Feb; 19(1):24. PubMed ID: 35115008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of six commercially available SARS-CoV-2 antibody assays-Choice of assay depends on intended use.
    Nilsson AC; Holm DK; Justesen US; Gorm-Jensen T; Andersen NS; Øvrehus A; Johansen IS; Michelsen J; Sprogøe U; Lillevang ST
    Int J Infect Dis; 2021 Feb; 103():381-388. PubMed ID: 33310021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.
    National SARS-CoV-2 Serology Assay Evaluation Group
    Lancet Infect Dis; 2020 Dec; 20(12):1390-1400. PubMed ID: 32979318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-SARS-CoV-2 IgM improves clinical sensitivity early in disease course.
    Higgins V; Fabros A; Wang XY; Bhandari M; Daghfal DJ; Kulasingam V
    Clin Biochem; 2021 Apr; 90():1-7. PubMed ID: 33476578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Clinical Performance of 7 Serological Assays for SARS-CoV-2 for Use in Clinical Laboratories.
    Plaga A; Wei R; Olson E; Payto D; Harrington J; Nwe-Kissig PT; Strizzi M; Zilka S; Ko J; Colón-Franco JM
    J Appl Lab Med; 2021 Jul; 6(4):998-1004. PubMed ID: 33825844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical and clinical evaluation of four commercial SARS-CoV-2 serological immunoassays in hospitalized patients and ambulatory individuals.
    Catry E; Jacqmin H; Dodemont M; Saad Albichr I; Lardinois B; de Fays B; Delaere B; Closset M; Laurent T; Denis O; Galanti L; Mullier F; Huang TD
    J Virol Methods; 2021 Mar; 289():114060. PubMed ID: 33359614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of commercial automated SARS-CoV-2 immunoassays.
    Kittel M; Muth MC; Zahn I; Roth HJ; Thiaucourt M; Gerhards C; Haselmann V; Neumaier M; Findeisen P
    Int J Infect Dis; 2021 Feb; 103():590-596. PubMed ID: 33310108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
    Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
    Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
    Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
    Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of commercial SARS-CoV-2 antibody assays, Jamaica.
    Butterfield TR; Bruce-Mowatt A; Phillips YZR; Brown N; Francis K; Brown J; Walker JP; McKnight NAL; Ehikhametalor K; Taylor DK; Bruce CA; McGrowder D; Wharfe G; Sandiford SL; Thompson TK; Anzinger JJ
    Int J Infect Dis; 2021 Apr; 105():333-336. PubMed ID: 33610776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
    Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in Performance Characteristics Among Four High-Throughput Assays for the Detection of Antibodies Against SARS-CoV-2 Using a Common Set of Patient Samples.
    Manthei DM; Whalen JF; Schroeder LF; Sinay AM; Li SH; Valdez R; Giacherio DA; Gherasim C
    Am J Clin Pathol; 2021 Feb; 155(2):267-279. PubMed ID: 33033840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies.
    Gutiérrez-Cobos A; Gómez de Frutos S; Domingo García D; Navarro Lara E; Yarci Carrión A; Fontán García-Rodrigo L; Fraile Torres AM; Cardeñoso Domingo L
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):955-961. PubMed ID: 33236268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.
    Valdivia A; Torres I; Latorre V; Francés-Gómez C; Albert E; Gozalbo-Rovira R; Alcaraz MJ; Buesa J; Rodríguez-Díaz J; Geller R; Navarro D
    Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):485-494. PubMed ID: 33404891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.